The decision to drop the deal came after U.S. District Judge Brian Martinotti refused to certify a class in the litigation, which also targets insulin drug makers Novo Nordisk and Sanofi.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
